Allient Inc.
🔔 Watch stock
Assessment
Our Rating
A journalistic assessment by our editorial team at the time of the deep dive — it rates the company, not the entry point. Not investment advice and not a solicitation to buy or sell.
Business model, numbers and balance sheet hold up to our review. Whether the current price supports an entry is a separate question — it hangs on the price, not on the company.
Why this colour
Quality confirmed: the operational turnaround is documented — gross margin up 150 basis points to 32.8 percent, operating margin from 5.7 to 7.9 percent, earnings up 70 percent, book-to-bill above one and net debt cut from $188.1 million to $139.7 million — and with covenants comfortably met, goodwill and cyclicality remain burdens to watch, not open operational wounds. The rating says nothing about the entry price — that is what the metrics scanners answer, with a price-to-earnings ratio around 62 and an average analyst price target below the recent price. The decision is yours.
What the thesis turns on
Assessment: Opportunities & Risks
Allient is a genuine strength story: the motion-technology specialist has delivered a documented operational turnaround (operating margin from 5.7 to 7.9 percent, net income +70 percent, order intake +15 percent) and fires in 23 scanners for good reason, from "Best of All" to the all-time high. The honest flip side is the price of that strength: $134 million of goodwill (23 percent of total assets) and $140 million of net debt from the buy-and-build strategy, cyclical end markets — and a stock that, after nearly tripling, is valued at a price-to-earnings ratio around 62 while the average analyst price target sits below the recent price. A very good company; the question is the entry price. Not investment advice.
Operating quality & turnaround
A genuine, documented improvement: gross margin up 150 basis points to 32.8 percent, operating margin from 5.7 to 7.9 percent, net income +70 percent — carried by the "Simplify to Accelerate NOW" program, not by one-off effects. In the first quarter of 2026, net income grew 51 percent.
Order book & demand
Order intake +15 percent to $550.9 million, backlog at $233 million, book-to-bill above one. Demand around data centers (power-quality solutions) supports the industrial segment and provides visibility beyond the day.
Balance sheet: goodwill & debt
The price of the buy-and-build strategy: $134.3 million of goodwill is roughly 23 percent of total assets and about 45 percent of equity (impairment risk). $139.7 million of net debt — reduced from $188.1 million, to be fair — with a $13.2 million interest bill that ties up roughly 30 percent of operating income. Covenants comfortably met.
Cyclicality of the end markets
Broad positioning across four end markets cushions swings, yet demand remains tied to the economy: in 2025 the industrial side boomed while the vehicle business (powersports, trucks) shrank. A broad downturn would hit the single-digit-margin supplier noticeably; beta around 1.6.
Valuation & price
Expensive after nearly tripling: price-to-earnings around 62 (forward around 34), EV/EBITDA around 24, price-to-sales around 2.5. The average analyst price target of roughly $73.80 sits below the recent price — the professionals see barely any upside. An all-time high means maximum altitude.
Worth Noting
Price and valuation figures dated mid-2026; analyses are evergreen, daily prices are not a buy argument. The market value of roughly $1.4 billion refers to roughly 17.0 million shares outstanding.
Net debt per the annual report (10-K) definition: financial debt of $180.4 million minus cash of $40.7 million equals $139.7 million (prior year: $224.2 minus $36.1 = $188.1 million). Under a broader definition including lease liabilities, net debt comes out somewhat higher; the multi-year chart uses this broader, consistent series for 2020–2023.
Allient reports in a single operating segment; the split by end markets (industrial, vehicles, medical, A&D) is a revenue disaggregation, not segment reporting. No single customer reached ten percent of revenue in 2025 or 2024 — a customer concentration risk expressly does not exist.
AI classification: neutral. The SEC filings reviewed contain no material AI exposure; the only mention of "artificial intelligence" is a generic cybersecurity boilerplate. The demand around data centers is an AI-adjacent end-market narrative, not a sale of own AI products.
Stock Watch
This analysis is as of August 4, 2026. Stock Watch will tell you what's changed at ALNT since then.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 42.10 $ to 114.30 $ · Last price: 99.10 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Electronic Components
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| Allient Inc. ALNT | 1.7 | 75.8 | 25.2 | 33.3 | 7.3 | 4.6 | 116.6 |
| Corning Incorporated GLW | 127.2 | 68.9 | 35.8 | 36.4 | 15.7 | 19.1 | 93.9 |
| Amphenol Corporation APH | 96.5 | 22.3 | 23.8 | 39.0 | 27.3 | 51.7 | 33.1 |
| TE Connectivity Ltd TEL | 59.8 | 20.2 | 13.2 | 36.1 | 20.8 | 7.9 | -3.5 |
| Flex Ltd FLEX | 41.0 | 41.3 | 20.9 | 9.5 | 5.7 | 8.1 | 93.1 |
| Jabil Circuit Inc JBL | 31.6 | 35.3 | 16.7 | 9.2 | 5.2 | 3.2 | 39.5 |
| Fabrinet FN | 14.4 | 30.6 | 20.6 | 12.0 | 9.9 | 18.6 | 6.3 |
| TTM Technologies Inc TTMI | 11.9 | 93.8 | 30.2 | 21.2 | 8.6 | 19.0 | 134.1 |
| Vicor Corporation VICR | 10.7 | 69.1 | 73.4 | 56.6 | 15.0 | 13.6 | 314.5 |
| Median of companies shown | 31.6 | 41.3 | 23.8 | 33.3 | 9.9 | 13.6 | 93.1 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 246 | 19 | 9 | 0.66 | 14 | 72 | 180 |
| 2017 | 252 | 19 | 8 | 0.58 | 25 | 87 | 188 |
| 2018 | 311 | 24 | 16 | 1.13 | 17 | 102 | 285 |
| 2019 | 371 | 29 | 17 | 1.20 | 35 | 119 | 306 |
| 2020 | 367 | 23 | 14 | 0.95 | 25 | 143 | 349 |
| 2021 | 404 | 26 | 24 | 1.66 | 25 | 188 | 471 |
| 2022 | 503 | 32 | 17 | 1.09 | 6 | 215 | 588 |
| 2023 | 579 | 42 | 24 | 1.48 | 45 | 252 | 598 |
| 2024 | 530 | 30 | 13 | 0.79 | 42 | 265 | 576 |
| 2025 | 554 | 48 | 22 | 1.32 | 57 | 301 | 578 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.18 | -31.10 | 122 | -13.50 | 2.50 | 12 | 10 |
| 2025: Q1 | 0.21 | -48.90 | 133 | -9.50 | 2.70 | 14 | 13 |
| 2025: Q2 | 0.34 | 384.60 | 140 | 2.60 | 4.00 | 25 | 22 |
| 2025: Q3 | 0.39 | 205.10 | 139 | 10.80 | 4.70 | 5 | 3 |
| 2025: Q4 | 0.38 | 109.30 | 143 | 17.50 | 4.50 | 14 | 12 |
| 2026: Q1 | 0.32 | 48.50 | 139 | 4.60 | 3.90 | 6 | 4 |
| 2026: Q2 | 0.61 | 79.40 | 154 | 10.20 | 6.80 | 14 | 9 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 25 of our scanner strategies — each hit links to the scanner.
Best Hits
Growth
Quality & Balance Sheet
Breakout & Setup
Momentum & Trend
- 21-EMA Trend
- Above the 50- & 200-SMA
- CANSLIM Type RS
- Gary Antonacci: Dual Momentum (Stock Adaptation)
- High ADR (≥5%)
- Mark Minervini: Trend Criteria — 1 Month
- Mike Webster: Power Trend Leader
- Near 52-Week High
- Qullamaggie: Top Gainers 1M
- Qullamaggie: Trend Intensity (13/65)
- RS Leader (≥90)
- RS New Highs
- Richard Moglen: Top Performers 3/6 Month
- Stage 2 Leader
- Stan Weinstein: Stage 2
- Strength on Stress Days
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2.74 | 2.68 – 2.84 | 602 | 26.1% | 5 |
| 12/31/2027 | 3.32 | 3.11 – 3.47 | 654 | 21.2% | 5 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Instead of guessing what the stock is worth, we turn the question around: what free cash flow growth has to happen for today’s market value to add up? The assumptions behind it can be moved.
Today’s market value implies roughly 23.0% growth in free cash flow per year over ten years (assumptions: discount rate 10.0%, terminal growth 2.5%).
| Free cash flow (last twelve months) | $27.5M |
|---|---|
| Market cap | $1.69B |
| Free cash flow in year ten | $218.4M |
| Terminal value as a share of market value | 68.2% |
For comparison: over the past five years free cash flow grew by 26.3% per year.
It shows which assumption is built into today’s price, not whether that assumption will hold. Every assumption can be changed with the sliders; the figures move with them.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Erneut geprüft am 10.07.2026 gegen den Geschäftsbericht (10-K) 2025 (eingereicht 05.03.2026) und die vier jüngsten Quartalsberichte (10-Q): In den ausgewerteten SEC-Filings von Allient findet sich kein wesentlicher KI-Bezug. Die einzige Erwähnung von „artificial intelligence“ ist eine generische Cybersecurity-Floskel im Item 1C des 10-K 2025 („Numerous and evolving cybersecurity threats, including artificial intelligence technologies, pose potential risks to the security of our IT systems…“) — weder KI-Umsatzquelle noch operativer KI-Einsatz noch konkretes KI-Geschäftsrisiko fürs eigene Modell. Allient profitiert zwar als Zulieferer von Antriebs- und Power-Quality-Technik von der Nachfrage rund um Rechenzentren („power quality solutions supporting data center infrastructure“ trieb 2025 das Industrie-Segment), doch das ist ein KI-nahes Endmarkt-Narrativ, kein Verkauf eigener KI-Produkte — nach dem Kriterienkatalog bleibt es damit bei „neutral“ (Endmarkt-Exponierung allein begründet kein „verkauft“). Befund gegenüber der Vor-Einstufung bestätigt.
View the full file — quotes, sources, reviewed filings
Filings Reviewed: 10-Q 2026-05-06 · 10-Q 2025-11-05 · 10-Q 2025-08-06 · 10-Q 2025-05-07 · 10-K 2026-03-05 · 10-K 2025-03-05
Rated on July 10, 2026 · How the Rating Is Built
Earnings calls
What the Earnings Calls Reveal
We reviewed ten earnings call transcripts of Allient (ALNT) covering fiscal quarters 2023-Q4 through 2026-Q1 in chronological order. The big picture holds up: management called the 2024 downturn precisely, the recovery arrived by mid-2025 as promised, and the 2024 savings program was delivered. What stands out, however, are several concrete, datable commitments that slipped or were quietly softened: the annual margin target for 2024, the time and cost frame of the Dothan transition, the inventory-turns goal of 3.5, and the 2025 savings target. Added to that are a lost powersports customer admitted only late and a data center growth engine that is never quantified despite repeated analyst questions.
Core guidance in the downturn honest and delivered
The central forecast of the series came on the 2024-Q2 call: a drop to an annualized run rate below 500 million USD and a return to stronger revenues by mid-2025. Both materialized: quarterly revenue of 125 million USD in 2024-Q3 and 122 million in 2024-Q4, with growth resuming in 2025-Q2 (up 3 percent, and up 17 percent year over year in 2025-Q4). The 2024-Q2 framing of a mid-teens adjusted EBITDA margin business was nearly fulfilled with 14.4 and 14.6 percent in 2025-Q2 and 2025-Q3, and the 10 million USD of savings for 2024 was confirmed as delivered on the 2024-Q4 call. Gross margin rose from the 29.9 percent low in 2024-Q2 to record levels above 33 percent, and leverage fell from about 3.0 at year-end 2024 to 1.78 in 2026-Q1. On the big points, management kept its word.
Dothan transition: timeline and cost frame missed
On the 2024-Q4 call management announced the transfer of Dothan assembly operations: one-time costs of 4 to 5 million USD, substantially incurred in 2025, full payback within a year, and initial benefits by late 2025. In 2025-Q3 the transfer was still said to be fully complete by year-end 2025. On the 2026-Q1 call, however, the transition was still ongoing: an additional 2 to 3 million USD of realignment costs was budgeted for 2026, stabilization was pushed to the end of the third quarter of 2026, and the cost benefits to the second half of 2026. The CEO himself conceded the challenges could have been identified better upfront. Both the time and the cost frame of the original commitment were missed.
Quietly dropped targets: 2024 margin and 3.5 inventory turns
In 2023-Q4 management explicitly reaffirmed its target of 100 basis points of annual operating margin improvement; instead, the 2024 operating margin fell from 7.3 to roughly 5.7 percent, bottoming at 3.6 percent in 2024-Q2. In parallel, the finance team named an inventory-turns goal of about 3.5 by year-end 2024, early 2025 at the latest, on the 2024-Q1 call; actual turns stood at 2.7 at year-end 2024, 3.1 in 2025-Q1 and only 3.2 at year-end 2025. Neither target was ever formally withdrawn, yet neither reappeared on later calls; from 2024-Q3 through 2025-Q1 the communication shifted to consistently positive sequential comparisons instead. In 2025 the margin promise was delivered late with a 7.9 percent operating margin and a record gross margin of 32.8 percent, while the turns goal remained unmet.
Lost powersports customer admitted only late
The declines in the vehicle segment (minus 38 percent in 2024-Q3, minus 46 percent in 2024-Q4, minus 34 percent in 2025-Q1) were consistently explained as market softness plus a deliberate focus on margin-enhancing applications. Only in 2025-Q3 did the CEO admit that the most important powersports customer had moved to a second source and that Allient had been losing a portion of that business for over a year. In 2024-Q4 there was merely the indirect hint that the customer no longer met the reporting threshold. The disclosure was honest but came about a year late and initially dressed a share loss up as strategy.
Data center revenue never quantified despite repeated asks
The power quality business for data centers has been the central growth story of the calls since 2024-Q3. Yet management consistently declines to quantify it: in 2024-Q3 the direct analyst question about revenue was answered only vaguely with millions in the high single digits or low double digits, in 2024-Q4 a growth rate of about 40 percent was given once, and in 2025-Q2 and 2025-Q3 answers again stayed qualitative. As competitive protection this is understandable and internally consistent. But leaving the most important growth driver unquantified across several quarters makes the story hard to verify.
Metrics changed: bookings logic and capex ranges
In 2026-Q1 management changed how bookings are recorded: instead of entire multi-year programs, only firmly scheduled production plans of roughly 3 to 6 months are now booked. This was disclosed openly and framed as more conservative, but it makes the record book-to-bill of 1.14 hard to compare with prior quarters. The capex guidance also shows a pattern: the 2024 range was cut from 16 to 20 million USD (2023-Q4) via 13 to 17 and 11 to 15 down to 8 to 11 million USD, with the prior range misquoted on the 2024-Q3 call; for 2025 the ratcheting down repeated from 10 to 12 down to 6.5 to 8.5 million USD. Capital discipline yes, capex forecasting quality rather weak.
Management promises
- 2023-Q4 — 100 basis points of annual operating margin improvement, split between gross margin and operating expenses; explicitly reaffirmed as a standing target on the call. In 2024 the operating margin fell from 7.3 to roughly 5.7 percent; the annual target was clearly missed and never formally withdrawn. In 2025 management delivered late with a 7.9 percent operating margin and a record gross margin. broken
- 2024-Q1 — Inventory turns of about 3.5 by the end of 2024, at the latest early 2025. Turns stood at 2.7 at year-end 2024, 3.1 in 2025-Q1 and 3.2 at year-end 2025. The goal was never reached and never mentioned again on any later call. broken
- 2024-Q2 — 10 million USD of annualized cost savings by the end of 2024 (5 million executed, another 5 million in the second half). Confirmed as delivered on the 2024-Q4 call: 10 million USD of annualized savings were realized in 2024; the sequential margin recovery from 2024-Q3 supports this. kept
- 2024-Q2 — Annualized revenue run rate to fall below 500 million USD for a few quarters, with a return to stronger revenue around mid-2025. Materialized precisely: quarterly revenue of 125 million USD in 2024-Q3 and 122 million in 2024-Q4; growth returned from 2025-Q2 (up 3 percent, up 17 percent year over year in 2025-Q4). One of the most accurate calls of the series. kept
- 2024-Q4 — Dothan transition: one-time costs of 4 to 5 million USD substantially in 2025, payback within a year, initial benefits by late 2025; per 2025-Q3 transfer fully complete by the end of 2025. In 2026-Q1 the transition was still ongoing, with an additional 2 to 3 million USD of costs for 2026, stabilization only by the end of Q3 2026 and benefits in the second half of 2026; the CEO openly conceded planning shortfalls. broken
- 2024-Q4 — Additional 6 to 7 million USD of annualized savings in 2025. Still called on track in 2025-Q2 and 2025-Q3, then on the 2025-Q4 call only meaningful progress, not complete; the remainder shifts into 2026 with no achieved figure disclosed. broken
- 2025-Q1 — Tariff impact of at most about 3 million USD for the remainder of 2025 before mitigation; no material earnings effect, costs largely passed through. In 2025-Q3 only an unrecovered net effect of about 385,000 USD in the quarter was reported, mainly in the power quality business; the impact stayed within the promised frame. kept
- 2025-Q4 — Expansion of the main facility for data center products fully operational in late second to early third quarter 2026. No completion confirmed on the 2026-Q1 call; the date is still in the future and remains to be watched. open
Based on public earnings call transcripts. Reviewed: 10 transcripts 2023-Q4 through 2026-Q1.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 3.3%
- More than 10% revenue growth is expected for the coming year 7.0%
- Share count grows by less than 3% a year 1.6%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 13.6%
- Gross margin at 40% or higher and without meaningful erosion 30.5%
- Goodwill from acquisitions does not grow faster than revenue 23.3%
- Net debt below twice EBITDA 2.0 x EBITDA
- Operating cash flow covers the profits of the last three years 84 m
- Return on capital at 15% or higher, or up versus two years ago 9.5%
- Insiders hold at least 10% or are net buyers 14.8%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
9/10 Quality stockThe AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 9.5%
- Exp. sales growth 3Y > 5% 8.6%
- EBIT growth 10Y > 5% 10.7%
- Exp. EBIT growth 3Y > 5% 58.7%
- Net debt < 4x EBIT 3.4x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 29.0%
- Return on equity > 15% 28.0%
- ROCE > 15% 9.4%
- Expected return > 10% 63.4%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Warzala Richard S | Chief Executive Officer | Other | 10,000 | – | – |
| Aug 10, 2026 | Warzala Richard S | Chief Executive Officer | Sell | 852 | 115.35 | 98,278 |
| Aug 10, 2026 | Warzala Richard S | Chief Executive Officer | Sell | 33,944 | 113.96 | 3,868,228 |
| Aug 10, 2026 | Warzala Richard S | Chief Executive Officer | Sell | 18,176 | 113.52 | 2,063,280 |
| Aug 10, 2026 | Warzala Richard S | Chief Executive Officer | Sell | 17,028 | 112.81 | 1,921,004 |
| Aug 5, 2026 | Winter Michael R | Director | Other | 291 | 93.25 | 27,136 |
| Aug 5, 2026 | Tzetzo Nicole R | Director | Other | 291 | 93.25 | 27,136 |
| Aug 5, 2026 | Finch Steven C. | Director | Other | 291 | 93.25 | 27,136 |
| Aug 5, 2026 | Federico Richard D | Director | Other | 331 | 93.25 | 30,866 |
| Aug 5, 2026 | Engel Robert B | Director | Other | 291 | 93.25 | 27,136 |
The company
About the Company
Allient Inc. entwirft, fertigt und verkauft zusammen mit seinen Tochtergesellschaften Präzisions- und Spezialkomponenten und -systeme für die Bewegungssteuerung für verschiedene Branchen in den USA, Kanada, Südamerika, Europa und im asiatisch-pazifischen Raum.
- Employees
- 2,478
- Headquarters
- Amherst, NY
- Address
- 495 Commerce Drive, 14228 Amherst, United States
- Phone
- 716 242 8634
- Website
- allient.com
- IPO Date
- 02/25/1992
- ISIN
- US0193301092
- Stock Split
- 3:2 on 05/03/2021
- Stock Split
- 3:2 on 04/12/1985
- Stock Split
- 2:1 on 11/01/1982
Management
| Name | Title | Birth Year |
|---|---|---|
| Richard S. Warzala | Chairman, CEO & President | 1953 |
| James A. Michaud | Senior VP & CFO | 1965 |
| Helmut D. Pirthauer | VP & Group President of Allied Dynamos Group | 1971 |
| Ashish A. Bendre | VP & Group President of Allied Orion Group | 1970 |
| Stephen R. Warzala | President of Allient Defense, Chief Growth Officer & Corporate VP | 1983 |
| Kenneth A. May | VP & CTO | 1965 |
| Alex Collichio | VP, General Counsel & Chief Administrative Officer | – |
| Robert Mastromattei | Chief Commercial Officer & Group President | – |
| Jackson Trostle | Corporate Controller | – |
| Nicholas Hoffman | Secretary | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.